Show simple item record

dc.contributor.authorBadia Castello, Mariona
dc.contributor.authorCasanova i Seuma, Josep M. (Josep Manel)
dc.contributor.authorServià Goixart, Lluís
dc.contributor.authorMontserrat, Neus
dc.contributor.authorCodina, Jordi
dc.contributor.authorTrujillano Cabello, Javier
dc.date.accessioned2021-04-29T07:33:54Z
dc.date.available2021-04-29T07:33:54Z
dc.date.issued2020-09-26
dc.identifier.issn2090-1313
dc.identifier.urihttp://hdl.handle.net/10459.1/71188
dc.description.abstractDermatological problems are not usually related to intensive medicine because they are considered to have a low impact on the evolution of critical patients. Despite this, dermatological manifestations (DMs) are relatively frequent in critically ill patients. In rare cases, DMs will be the main diagnosis and will require intensive treatment due to acute skin failure. In contrast, DMs can be a reflection of underlying systemic diseases, and their identification may be key to their diagnosis. On other occasions, DMs are lesions that appear in the evolution of critical patients and are due to factors derived from the stay or intensive treatment. Lastly, DMs can accompany patients and must be taken into account in the comprehensive pathology management. Several factors must be considered when addressing DMs: on the one hand, the moment of appearance, morphology, location, and associated treatment and, on the other hand, aetiopathogenesis and classification of the cutaneous lesion. DMs can be classified into 4 groups: life-threatening DMs (uncommon but compromise the patient’s life); DMs associated with systemic diseases where skin lesions accompany the pathology that requires admission to the intensive care unit (ICU); DMs secondary to the management of the critical patient that considers the cutaneous manifestations that appear in the evolution mainly of infectious or allergic origin; and DMs previously present in the patient and unrelated to the critical process. (is review provides a characterization of DMs in ICU patients to establish a better identification and classification and to understand their interrelation with critical illnesses.
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherHindawi
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1155/2020/9729814
dc.relation.ispartofCritical Care Research and Practice, 2020, vol. 2020, p. 9729814
dc.rightscc-by (c) Badia et al., 2020
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.otherDermatologia
dc.subject.otherUnitats de cures intensives
dc.titleDermatological Manifestations in the Intensive Care Unit: A Practical Approach
dc.typeinfo:eu-repo/semantics/article
dc.date.updated2021-04-29T07:33:54Z
dc.identifier.idgrec030763
dc.type.versionpublishedVersion
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.identifier.doihttps://doi.org/10.1155/2020/9729814


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

cc-by (c) Badia et al., 2020
Except where otherwise noted, this item's license is described as cc-by (c) Badia et al., 2020